{"Abstract": [0], "Given": [1], "the": [2, 10, 29, 36, 73, 101, 120, 144, 173, 180, 185, 197, 204, 209], "increasing": [3], "prevalence": [4], "of": [5, 13, 55, 70, 123, 132, 151, 157, 175, 182, 199, 206, 237], "diabetes": [6], "and": [7, 52, 84, 93, 111, 125, 128, 134, 161, 172, 191, 196, 222, 239], "obesity": [8], "worldwide,": [9], "deleterious": [11], "effects": [12], "non-alcoholic": [14], "fatty": [15], "liver": [16, 33, 56, 91, 112, 141], "disease": [17, 34], "(NAFLD)": [18], "are": [19, 217, 225], "becoming": [20], "a": [21, 63, 67], "growing": [22], "challenge": [23], "for": [24, 66], "public": [25], "health.": [26], "NAFLD": [27, 39, 61, 135, 152, 238], "is": [28, 40, 62, 87, 119, 136, 153, 187, 211], "most": [30], "common": [31, 64], "chronic": [32], "in": [35, 229], "Western": [37], "world.": [38], "closely": [41], "associated": [42], "with": [43, 140, 164, 213], "metabolic": [44, 177, 201], "disorders,": [45], "including": [46], "central": [47], "obesity,": [48], "dyslipidaemia,": [49], "hypertension,": [50], "hyperglycaemia": [51], "persistent": [53], "abnormalities": [54], "function": [57], "tests.": [58], "In": [59, 114], "general": [60], "denominer": [65], "broad": [68], "spectrum": [69], "damage": [71], "to": [72, 79, 100, 147, 219], "liver,": [74], "which": [75], "can": [76, 94], "be": [77], "due": [78], "hepatocyte": [80], "injury,": [81], "inflammatory": [82], "processes": [83], "fibrosis.": [85, 167], "This": [86, 232], "normally": [88], "seen": [89], "on": [90], "biopsy": [92, 142], "range": [95], "from": [96], "milder": [97], "forms": [98, 104], "(steatosis)": [99], "more": [102], "severe": [103], "(non-alcoholic": [105], "steatohepatitis": [106], "(NASH),": [107], "advanced": [108, 117], "fibrosis,": [109], "cirrhosis": [110], "failure).": [113], "these": [115], "patients,": [116], "fibrosis": [118], "major": [121], "predictor": [122], "morbidity": [124], "liver-related": [126], "mortality,": [127], "an": [129, 235], "accurate": [130], "diagnosis": [131, 186, 210], "NASH": [133], "mandatory.": [137], "Histologic": [138], "evaluation": [139], "remains": [143], "gold": [145], "standard": [146], "diagnose": [148], "NAFLD.": [149], "Diagnosis": [150], "defined": [154], "as": [155], "presence": [156], "hepatic": [158], "steatosis,": [159], "ballooning": [160], "lobular": [162], "inflammation": [163], "or": [165], "without": [166], "Weight": [168], "loss,": [169, 195], "dietary": [170], "modification,": [171], "treatment": [174, 198, 241], "underlying": [176, 200], "syndrome": [178, 202], "remain": [179, 203], "mainstays": [181, 205], "therapy": [183, 207], "once": [184, 208], "established.": [188], "Dietary": [189], "recommendations": [190], "lifestyle": [192], "interventions,": [193], "weight": [194], "established": [212], "promising": [214], "results": [215], "but": [216], "difficult": [218], "maintain.": [220], "Pioglitazone": [221], "vitamin": [223], "E": [224], "recommended": [226], "by": [227], "guidelines": [228], "selected": [230], "patients.": [231], "review": [233], "gives": [234], "overview": [236], "its": [240], "options.": [242]}